ArticleEmerging infectious diseases2009
Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007.
Article in Emerging infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- Burden of invasive group B Streptococcus disease in non-pregnant adults: A systematic review and meta-analysis.PloS one · 2021Pooled it
- Article
- HylS', a fragment of truncated hyaluronidase ofVirulence · 2024Article
- Group B Streptococcus Infections in Non-Pregnant Adults, Italy, 2015-2019.Pathogens (Basel, Switzerland) · 2024Article
- Serious Bacterial Infections Associated with Eculizumab: A Pharmacovigilance Study.Internal medicine (Tokyo, Japan) · 2024Article
- Article
- Group B streptococcal colonization in elderly women.BMC infectious diseases · 2021Observational
- Genome-Wide Assessment of Streptococcus agalactiae Genes Required for Survival in Human Whole Blood and Plasma.Infection and immunity · 2020Article
- Risk Factors and Mortality Rates Associated With Invasive Group B Streptococcus Infections Among Patients in the US Veterans Health Administration.JAMA network open · 2019Article
- Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016.JAMA internal medicine · 2019Article
- Group BMicrobiology spectrum · 2019Review
- A comparison of Streptococcus agalactiae septic arthritis and non-Streptococcus agalactiae septic arthritis.Singapore medical journal · 2018Article
- Immune Responses to Invasive Group B Streptococcal Disease in Adults.Emerging infectious diseases · 2016Article
- Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.Journal of clinical microbiology · 2016Article
- Molecular Mechanisms of Inhibition of Streptococcus Species by Phytochemicals.Molecules (Basel, Switzerland) · 2016Review
- Group B Streptococcus vaccine: state of the art.Therapeutic advances in vaccines · 2015Review
- Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada.Emerging infectious diseases · 2015Article
- Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.Journal of clinical microbiology · 2014Article
- Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010.Emerging infectious diseases · 2013Article
- Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.Journal of clinical microbiology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Minnesota, incidence of invasive group B streptococcal disease was 3 times greater in older adults in long-term care facilities than in older adults in community settings (67.7/100,000 vs. 21.4/100,000) during 2003-2007. The overall case-fatality rate was 6.8%, and concurrent conditions were common among both groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.